CIK 0001738021 · Non-accelerated filer<br>Smaller reporting company
Compass Therapeutics, Inc.
Sign in to watch- Ticker
- CMPX
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- 617-500-8099
- Business address
- 80 GUEST STREET, BOSTON, MA, 02135
- Former names
- Olivia Ventures, Inc.
- 4 Open-market sale Director sold 3,571,428 shares at $1.59 ($5,678,571)
- 4 Open-market sale Director sold 3,571,428 shares at $1.59 ($5,678,571)
- SCHEDULE 13D/A Stake Beneficial Ownership Report
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 4 Open-market buy Gen Counsel & Corporate Sec bought 20,000 shares at $1.54 ($30,800)
- 4 Open-market buy CHIEF ACCOUNTING OFFICER bought 20,000 shares at $1.42 ($28,400)
- 8-K Event Regulation FD disclosure · Other events
- S-8 Other Securities Offered to Employees in Benefit Plans
- 10-K Report Annual Report
- 8-K Event Results of operations
- SCHEDULE 13G Stake Statement of Beneficial Ownership
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
Page 5 of 19 · 362 filings